Anthralin (dithranol) in vitro inhibits human monocytes to secrete IL-6, IL-8 and TNF-α, but not IL-1
- 1 April 1997
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 136 (4) , 542-547
- https://doi.org/10.1111/j.1365-2133.1997.tb02138.x
Abstract
No abstract availableThis publication has 36 references indexed in Scilit:
- Inhibition of 12-O-Tetradecanoylphorbol-13-Acetate and Other Skin Tumor-Promoter-Caused Induction of Epidermal Interleukin-1α mRNA and Protein Expression in SENCAR Mice by Green Tea PolyphenolsJournal of Investigative Dermatology, 1995
- The inflammatory infiltrate in psoriasisClinics in Dermatology, 1995
- Treatment of Psoriasis with Anthrones-Chemical Principles, Biochemical Aspects, and Approaches to the Design of Novel DerivativesSkin Pharmacology and Physiology, 1995
- Inhibition of anthralin-caused skin tumor promotion and interleukin-1α production by potent immunosuppressant FK506Cancer Letters, 1994
- Modulation of interleukin‐1α mRNA expression in mouse epidermis by tumor promoters and antagonistsMolecular Carcinogenesis, 1993
- Inhibition of human monocyte functions by anthralinBritish Journal of Dermatology, 1992
- Monocyte and neutrophil chemotaxis in psoriasis: Relation to the clinical status and the type of psoriasisJournal of the American Academy of Dermatology, 1986
- Mulitfunctional Inhibition by Anthralin in Nonstimulated and Chemotactic Factor Stimulated Human NeutrophilsJournal of Investigative Dermatology, 1985
- Stimulus-Dependent Increased Generation of Oxygen Intermediates in Monocytes and Polymorphonuclear Leukocytes in PsoriasisJournal of Investigative Dermatology, 1985
- Skin permeability of anthralinBritish Journal of Dermatology, 1981